β-Blocker use in elderly ED patients with acute myocardial infarction

American Journal of Emergency Medicine

Volumn 24, Issue 4, 2006, Pages 435-439

  Vega, David D ^a   Dolan, Kendra L ^a   Pollack, Marc L ^a  

^a YORK HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRONCHOSPASM; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EMERGENCY WARD; ERECTILE DYSFUNCTION; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; CHI-SQUARE DISTRIBUTION; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALS, COMMUNITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 33745169357     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2005.12.017     Document Type: Article

References (22)

1. Ryan T.J., Antman E.M., Brooks N.H., Califf R.M., Hillis L.D., Hiratzka L.F., et al. ACC/AHA 1999 guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 100 (1999) 1016-1030
2. Maroko P.R., Kjekshus J.K., Sobel B.E., et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43 (1971) 67-82
3. β-Blocker Heart Attack Trial Research Group. A randomized trial of propanolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247 (1982) 1707-1714
4. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. Eur Heart J 6 (1985) 199-226
5. First International Study of Infarct Survival Collaborative Group. Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2 (1986) 57-66
6. Yusuf S., Peto R., Lewis J., Collins R., and Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27 (1985) 335-371
7. Galcera-Tomas J., Castillo-Soria F.J., Villegas-Garcia M.M., et al. Effects of early use of atenolol or captopril on infarct size and ventricular volume: a double-blind comparison in patients with anterior acute myocardial infarction. Circulation 103 6 (2001) 813-819
8. Ryden L., Ariniego R., Arnman K., et al. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 308 (1983) 614-618
9. Ahnve S., Erhardt L., Lundman T., et al. Effect of metoprolol on QTc intervals after acute myocardial infarction. Acta Med Scand 208 3 (1980) 223-228
10. Evrengul H., Dursunoglu D., Kayikcioglu M., et al. Effects of a beta-blocker on ventricular late potentials in patients with acute anterior myocardial infarction receiving successful thrombolytic therapy. Jpn Heart J 45 1 (2004) 11-21
11. O'Bryan M.M., and Banas J.S. Intravenous beta-blockers in acute myocardial infarction: perceived versus actual use by cardiologists and emergency physicians. Am J Emerg Med 16 (1998) 623-626
12. French W.J. Trends in acute myocardial infarction management. Use of the national registry of myocardial infarction in quality improvement. Am J Cardiol 85 (2000) 5B-9B
13. Gunnar R.M., Bourdillon P.D.V., Dixon D.W., et al. Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol 16 (1990) 249-252
14. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 320 (1989) 618-627
15. Yusuf S. Early intravenous beta blockade in acute myocardial infarction. Postgrad Med Spec No (1988) 90-95
16. Pancu D., and Lee D.C. Beta-blocker use in the emergency department in patients with acute myocardial infarction undergoing primary angioplasty. J Emerg Med 24 (2003) 379-382
17. Krumholz H.M., et al. Early β-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med 131 (1999) 648-654
18. McLaughlin T.J., Soumerai S.B., Willison D.J., et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for under treatment in women and the elderly. Arch Intern Med 156 7 (1996) 799-805
19. Gerwitz J.H., Goldberg R.J., Chen Z., et al. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med 93 6 (1992) 605-610
20. Ellison K.E., and Gandhi G. Optimising the use of beta-adrenoceptor antagonist in coronary artery disease. Drugs 65 6 (2005) 787-797
21. Chen J., Radford M.J., Wang Y., et al. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol 37 7 (2001) 1950-1956
22. Bradley E.H., Herrin J., Mattera J.A., Holmboe E.S., et al. Quality improvement efforts and hospital performance rates of beta-blocker prescription after acute myocardial infarction. Med Care 43 3 (2005) 282-292